Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지

The Relationship between Serum Ferritin and Bone Mineral Density

  • Jo, Yoon-Kyung (Department of Clinical Laboratory Science, Dongnam Health College) ;
  • Seok, Ju-Won (Department C!f Nuclear Medicine, Chung-ang University Hospital) ;
  • Kim, Jung-Ha (Department of Family Medicine, Chung-ang University Hospital)
  • ;
  • ;
  • 김정하 (중앙대학교병원 가정의학과)
  • Received : 2010.10.29
  • Accepted : 2010.11.09
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Several risk factors for osteoporosis are known relatively well. Some nutrients are directly or indirectly needed for metabolic processes related to bone. Recently, an increased prevalence of osteoporosis has been reported in patients with hemochromatosis, an iron overload disease. Thus, the aim of this study was to find out if there was any relationship between serum ferritin and T-score of bone mineral density in healthy women. We recruited 1,101 subjects females aged between 39 and 85 years. We measured serum ferritin, glucose tolerance indices, lipid profiles, inflammatory indices, hormones, calcium, alkaline phosphatase. Also, anthropometric, blood pressure, and bone mineral density measurements were performed. T-score was negatively correlated with age (r=-0.425; P<0.01), systolic (r=-0.109; P<0.01) and diastolic (r=-0.093; P<0.01) pressure, follicular stimulation hormone (r=-0.190; P<0.01), alkaline phosphatase (r=-0.235; P<0.01), and serum ferritin (r=-0.090; P<0.05) and positively with body mass index (r=0.050; P=0.01), HDL-cholesterol (r=0.314; P<0.01), and estradiol (r=0.200; P<0.01). After adjustment for age, alkaline phosphatase, body mass index, HDL-cholesterol, estradiol, and follicular stimulation hormone, serum ferritin was independently inversely correlated with T-score (${\beta}$=-0.001; P<0.05). It is possible that an increase of serum ferritin in females be risk to osteoporosis.

Keywords

References

  1. Altindag O, Erel O, Soran N, Celik H, Selek S. Total oxidative/ anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008. 28: 317-321. https://doi.org/10.1007/s00296-007-0452-0
  2. Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. Journal of Bone and Mineral Research. 1997. 12: 1075-1082. https://doi.org/10.1359/jbmr.1997.12.7.1075
  3. Cummings SR, Blaek DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM. Bone density at various sites for prediction of hip fractures. The Lancet 1993. 341: 72-75. https://doi.org/10.1016/0140-6736(93)90490-8
  4. Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 1991. 6: 39-43.
  5. Diamond T, Stiel D, Lunzre M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1999. 31: 82-87.
  6. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007. 50: 949-956. https://doi.org/10.1007/s00125-007-0604-5
  7. Gardsell P, Johnell O, Nilsson BE, Gullberg B. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcified Tissue International 1993. 52: 348-353. https://doi.org/10.1007/BF00310197
  8. Isaia G, D'Amelio P, Di Bella S, Tamone C. Protein intake: the impact on calcium and bone homeostasis. J Endocrinol Invest. 2007.30: 48-53.
  9. Lalor BC, France MW, Powel D, Adams PH, Counichan TB. Bone and mineral metabolism and chronic alcohol abuse. QJ Med. 1986. 59: 497-511.
  10. Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses. 1991. 35: 96-102. https://doi.org/10.1016/0306-9877(91)90030-3
  11. Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D. Canadian Multicentre Osteoporosis Study (CaMos) Research Group. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int. 2010. Oct 22.
  12. Olsson R, Johansson C, Lindstedt G, Mellstrom D. Risk factor for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol. 1994.29: 743-756.
  13. Ramakrishnan U, Kuklina E, Stein AD. Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr. 2002. 76: 256-260.
  14. Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin. 2006. 22: 211-216. https://doi.org/10.1185/030079906X80369
  15. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992. 86: 803-811. https://doi.org/10.1161/01.CIR.86.3.803
  16. Shin CS, Choi HJ, Kim MJ, Kim JT, Yu SH, Koo BK, Cho HY, Cho SW, Kim SW, Park YJ, Jang HC, Kim SY, Cho NH. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone 2010. 47: 378-387. https://doi.org/10.1016/j.bone.2010.03.017
  17. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Pipemo A, Fiorelli G. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol. 1997. 24: 1809-1813.
  18. Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA. Predictive value of low BMD for I-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA). Journal of Bone and Mineral Research 2004. 19: 1215-1220. https://doi.org/10.1359/JBMR.040508
  19. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987. 7: 137-142. https://doi.org/10.1002/hep.1840070127
  20. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988. 29: 378-384. https://doi.org/10.1136/gut.29.3.378
  21. Tussing L, Chapman-Novakofski K. Osteoporosis prevention education: behavior theories and calcium intake. J Am Diet Assoc. 2005. 105: 92-97. https://doi.org/10.1016/j.jada.2004.10.025
  22. Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int. 2009. 20: 549-555. https://doi.org/10.1007/s00198-008-0701-4
  23. Wasnich RD, Ross PD, Heilbrun LL, Vogel JM. Selection of the optimal skeletal site for fracture risk prediction. Clinical Orthopaedics and Related Research 1987. 216: 262-269.
  24. Williams MJ, Poulton R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002. 165: 179-184. https://doi.org/10.1016/S0021-9150(02)00233-2
  25. World Health Organization. Prevention and Management of Osteoporosis. Report of a WHO Scientific Group WHO Technical Report Series, No 921. 2003.
  26. Yamasaki K, Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicology Letters 2009. 191: 211-215. https://doi.org/10.1016/j.toxlet.2009.08.023
  27. Yousefladeh G, Larijani B, Mohammadirad A, Heshrnat R, Dehghan G, Rahimi R, Abdollahi M. Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann N Y Acad Sci. 2006. 1091: 142-150. https://doi.org/10.1196/annals.1378.062